Skip to main content
OpenTrials

Clinical trial condition

Paroxysmal Supraventricular Tachycardia

Explore clinical trials studying Paroxysmal Supraventricular Tachycardia. Study availability and eligibility vary by location and protocol.

12 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Paroxysmal Supraventricular Tachycardia trial results

Recruiting

The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

NCT05763953

Conditions
Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Diseases, +6 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Advocate Children's Hospital Oak Lawn, Illinois, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia

NCT04952610

Conditions
Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Diseases, +6 more
Locations
  • Site # 0160 Little Rock, Arkansas, United States
  • Site # 1023 Vista, California, United States
  • Site # 1083 West Hills, California, United States
  • Site # 0102 Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Completed

Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia

NCT05410860

Conditions
Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Diseases, +7 more
Locations
  • Baotou Central Hospital Baotou, China
  • The First Affiliated Hospital of Baotou Medical College Baotou, China
  • Beijing Anzhen Hospital; Capital Medical University Beijing, China
  • Beijing Hospital Beijing, China
View all 53 locations
View Trial Details
Completed

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303

NCT04072835

Conditions
Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Diseases, +6 more
Locations
  • 1077 Gilbert, Arizona, United States
  • 1121 Fremont, California, United States
  • 1035 Stanford, California, United States
  • 1023 Vista, California, United States
View all 124 locations
View Trial Details

Related conditions